Will CTI BioPharma Corp (NASDAQ:CTIC) Breakout?

CTI BioPharma Corp (NASDAQ:CTIC) stock went up double digit on Friday.

Market Action

On Friday, CTIC stock moved up 10.43% to end the session at $2.54. More than 1.25 million shares exchanged hands for the day, compared to its average volume of 1.03 million shares. The stock opened at $2.31 and moved within a range of $2.2900 – 2.5800.

CTIC Business Description

We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need.

In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in Seattle, Washington.

Trader Notes

Share Information

SHARE FLOAT (%)85.93 M (92.12%)

Recent Stock Performance

5-DAY PERF.+16.51%
1-MONTH PERF.+8.09%
3-MONTH PERF.-22.80%
6-MONTH PERF.-31.54%
YTD PERF.-21.12%
1-YEAR PERF.+149.02%

Moving Averages

+/- EMA(20)2.35 (+8.09%)
+/- SMA(50)2.58 (-1.55%)
+/- SMA(200)2.72 (-6.62%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Technical Indicators

CCI2084.7817BuyChaikin Money Flow-0.2674Sell
MACD-0.0987SellMoney Flow Index27.3216Buy
STOCH (14,3)90.6977OverBoughtSTOCH RSI1.0000OverBought
UO47.6633BuyWilliams %R-9.3023OverBought

Related Posts

About The Author